CVR pays $4M FCA settlement for unnecessary procedures
Summary
Center for Vein Restoration (CVR) Management LLC agreed to pay $4 million to settle False Claims Act allegations that it billed Medicare, Medicaid, and TRICARE for medically unnecessary vein procedures. The settlement resolves two qui tam actions filed in 2015 and 2018, with proceeds distributed among eight state Medicaid programs, DC, the federal government, and the original whistleblowers.
What changed
CVR Management LLC, which operates the Center for Vein Restoration, agreed to pay $4 million to resolve allegations of fraudulent billing to government healthcare programs. The settlement stems from two qui tam lawsuits filed in the U.S. District Court for the District of Maryland (2015) and the Eastern District of Pennsylvania (2018), later consolidated in Maryland. The government alleged that CVR knowingly billed for sclerotherapy, radiofrequency ablation, and endovenous laser ablation procedures that were not clinically indicated or medically necessary. Federal programs only cover these treatments when chronic venous insufficiency is accompanied by specific conditions and when alternative treatments have failed; pure cosmetic treatment of varicose veins is not covered.
Healthcare providers performing procedures reimbursed by federal healthcare programs should review their medical necessity documentation practices to ensure procedures meet coverage criteria. Providers should verify that clinical records demonstrate the required conditions and failed conservative treatments before billing government programs. This settlement underscores continued federal and state enforcement focus on healthcare fraud involving medically unnecessary procedures, with multiple state attorneys general actively partnering in False Claims Act investigations.
What to do next
- Audit medical necessity documentation for procedures billed to Medicare, Medicaid, and TRICARE
- Ensure clinical records demonstrate coverage criteria are met before billing government programs
- Train staff on federal healthcare program coverage limitations for vein procedures
Penalties
$4 million settlement for fraudulent billing; potential exclusion from federal healthcare programs for continued violations
Archived snapshot
Apr 3, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
April 3, 2026
Center for Vein Restoration Enters Into $4M False Claims Act Settlement With States and Federal Government
Matthew Berns, Jessica Birdsong, Christopher Carlson, Lauren Morgan Fincher, Samuel Fishel, Clayton Friedman, Sydney Goldberg, Nick Gouverneur, Troy Homesley, Jeff Johnson, Namrata Kang, Stephanie Kozol, Michael Lafleur, William LaRosa, Warren Jay Myers, Philip Nickerson, Lane Page, Dascher Pasco, Stephen Piepgrass, Kyara Rivera Rivera, Zoe Schloss, Timothy Shyu, Trey Smith, Ashley Taylor Jr., Daniel Waltz, Michael Yaghi Troutman Pepper Locke + Follow Contact LinkedIn Facebook X Send Embed
Connecticut Attorney General (AG) William Tong announced on March 20, 2026, that Connecticut has joined with other states and the federal government to reach a settlement with CVR Management, LLC, the entity that manages the Center for Vein Restoration (CVR), resolving allegations that the company billed government health programs for medically unnecessary procedures. The settlement requires CVR Management to pay $4 million, which will be distributed among the Medicaid programs of eight states, the District of Columbia, the federal government, and the relators of the original lawsuits.
This settlement arises from two qui tam actions filed in the U.S. District Courts for the District of Maryland (2015) and for the Eastern District of Pennsylvania (2018), which were later consolidated in Maryland. CVR provides care for chronic venous insufficiency, including sclerotherapy, radiofrequency ablation, and endovenous laser ablation. The settlement resolves allegations that CVR fraudulently billed government health programs, including Medicare, Medicaid, and TRICARE, for procedures that were not clinically indicated or medically necessary.
Both the Connecticut press release and the U.S. Attorney’s Office for the District of Maryland press release emphasize that the procedures provided by CVR are only covered by federal programs when chronic venous insufficiency is accompanied by other specific conditions and when alternative treatments have been unsuccessful. The federal programs do not cover the treatment of varicose veins for purely cosmetic reasons, and the settlement alleges that “CVR knowingly billed….[for] procedures that were not clinically indicated and were medically unnecessary.”
Tong emphasized that he will continue to partner with other states and federal programs “to aggressively protect the integrity of our public healthcare programs.”
This settlement underscores the continued focus of the federal and state governments on health care billing practices, medical necessity determinations, and enforcement actions under the False Claims Act. Additionally, organizations like CVR that practice in multiple jurisdictions and bill to various government programs should be aware that coordinated investigations like this one can result in simultaneous exposure with both the federal and state enforcement authorities, including state AGs.
Latest Posts
- Tennessee Enacts Health Care AI Bill With Private Right of Action
- Center for Vein Restoration Enters Into $4M False Claims Act Settlement With States and Federal Government
- Fourth Circuit Blocks West Virginia’s 340B Contract Pharmacy Law as Likely Preempted
- CBP’s CAPE Crusade: A New 45-Day Path to IEEPA Duty Refunds
- NAIC Signals Potential Tightening of Annuity Illustration Practices See more »
DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
Attorney Advertising.
©
Troutman Pepper Locke
Written by:
Troutman Pepper Locke Contact + Follow Matthew Berns + Follow Jessica Birdsong + Follow Christopher Carlson + Follow Lauren Morgan Fincher + Follow Samuel Fishel + Follow Clayton Friedman + Follow Sydney Goldberg + Follow Nick Gouverneur + Follow Troy Homesley + Follow Jeff Johnson + Follow Namrata Kang + Follow Stephanie Kozol + Follow Michael Lafleur + Follow William LaRosa + Follow Warren Jay Myers + Follow Philip Nickerson + Follow Lane Page + Follow Dascher Pasco + Follow Stephen Piepgrass + Follow Kyara Rivera Rivera + Follow Zoe Schloss + Follow Timothy Shyu + Follow Trey Smith + Follow Ashley Taylor Jr. + Follow Daniel Waltz + Follow Michael Yaghi + Follow more less
PUBLISH YOUR CONTENT ON JD SUPRA
- ✔ Increased readership
- ✔ Actionable analytics
- ✔ Ongoing writing guidance Join more than 70,000 authors publishing their insights on JD Supra
Published In:
Department of Justice (DOJ) + Follow Enforcement Actions + Follow False Billing + Follow False Claims Act (FCA) + Follow Government Investigations + Follow Health Care Providers + Follow Healthcare + Follow Healthcare Fraud + Follow Medicaid + Follow Medicare + Follow Qui Tam + Follow Settlement + Follow State Attorneys General + Follow General Business + Follow Health + Follow Insurance + Follow more less
Troutman Pepper Locke on:
"My best business intelligence, in one easy email…"
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign Up Log in ** By using the service, you signify your acceptance of JD Supra's Privacy Policy.* - hide - hide
Named provisions
Related changes
Get daily alerts for JD Supra Healthcare
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from CT AG / USAO MD.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when JD Supra Healthcare publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.